Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Denali Therapeutics Inc., 3 years.
Denali Therapeutics Inc.
Director
Guardant Health Inc.
Director
Pliant Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2024 | Guardant Health Inc. | Option exercise | +5,592 | — | — |
| May 31, 2024 | Denali Therapeutics Inc. | Grant or award | +5,967 | — | — |
| May 31, 2024 | Guardant Health Inc. | Option exercise | +155 | — | — |
| Apr 30, 2024 | Guardant Health Inc. | Option exercise | +154 | — | — |
| Apr 1, 2024 | Denali Therapeutics Inc. | Open-market sale | −92,500 | $20.50 | $1,896,250 |
| Mar 31, 2024 | Guardant Health Inc. | Option exercise | +154 | — | — |
| Feb 29, 2024 | Guardant Health Inc. | Option exercise | +154 | — | — |
| Feb 13, 2024 | Denali Therapeutics Inc. | Open-market sale | −2,750 | $17.29 | $47,548 |
| Jan 31, 2024 | Guardant Health Inc. | Option exercise | +155 | — | — |
| Jan 5, 2024 | Denali Therapeutics Inc. | Open-market sale | −3,208 | $19.43 | $62,331 |
| Dec 31, 2023 | Guardant Health Inc. | Option exercise | +154 | — | — |
| Nov 30, 2023 | Guardant Health Inc. | Option exercise | +154 | — | — |
| Oct 31, 2023 | Guardant Health Inc. | Option exercise | +154 | — | — |
| Sep 30, 2023 | Guardant Health Inc. | Option exercise | +155 | — | — |
| Aug 31, 2023 | Guardant Health Inc. | Option exercise | +154 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.